EGFR is mutated in 10–20% of lung adenocarcinomas among Caucasian patients and more commonly in young never-smoker Asian women, whereas EGFR mutations are rare in other lung cancer subtypes [10,11]. This evidence concerns the gene EGFR and lung carcinoma.